Interim FDG‐PET has no value in selecting patients who require treatment modification in both early‐ and advanced‐stage Hodgkin lymphoma: response to Adams and Kwee

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles